Ringside · Post-Bell · September 8
- Amgen ended 10.08% weaker at $393.17 once a competitor's cholesterol drug missed its goal.
- Houthi strikes halted Saudi energy sites and Brent settled at $99.29, within $0.71 of $100.
- Intel jumped 9.1% to $104.47 on a report it will raise processor prices in October.
Indexes
Coming back from Labor Day, this market found two separate problems and priced them in two different places. The Dow Jones Industrial Average lost 628.18 points, or 1.18%, roughly twice the S&P 500's 0.58% decline, and the arithmetic behind that gap runs through one name: Amgen closed down 10.08% after a competing cholesterol therapy failed its outcomes study, and because the Dow weights members by share price, a $44 fall travels further there. Health care was the weakest of the eleven sectors at 2.52% lower, with only energy, utilities and technology higher. The second problem was crude, where West Texas Intermediate settled at a three-month high, pulling the airlines down while lifting the producers. The S&P 500 closed at 7,673.52, less than seven points off its session low, surrendering the twenty-day average it had reclaimed on Thursday.
| Index | Close | % Chg | Session range |
|---|---|---|---|
| S&P 500 | 7,673.52 | -0.58% | 7,666.99 – 7,717.81 |
| Nasdaq Composite | 26,421.41 | -0.32% | 26,341.17 – 26,542.14 |
| Dow Jones Industrial Average | 52,786.07 | -1.18% | 52,721.62 – 53,110.45 |
| Russell 2000 | 2,960.20 | -0.52% | 2,958.65 – 2,975.48 |
| Volatility index (VIX) | 15.72 | +2.75% | — |
Sector Heat Map
| Sector (ETF) | Close | % Chg |
|---|---|---|
| Energy (XLE) | $64.77 | +1.11% |
| Utilities (XLU) | $43.45 | +0.86% |
| Technology (XLK) | $187.87 | +0.32% |
| Real Estate (XLRE) | $43.90 | -0.07% |
| Communication Services (XLC) | $111.52 | -0.46% |
| Industrials (XLI) | $174.42 | -0.48% |
| Consumer Staples (XLP) | $84.02 | -0.66% |
| Consumer Discretionary (XLY) | $113.99 | -0.80% |
| Materials (XLB) | $51.94 | -0.95% |
| Financials (XLF) | $57.30 | -1.38% |
| Health Care (XLV) | $167.13 | -2.52% |
Health care lost more than the next two weakest groups combined, and what sat below it describes no tidy rotation, with staples and real estate down alongside discretionary and materials. This was a market willing to own the oil price and the power bill, and reluctant about most of the rest.
In the News
Rates, FX, Commodities
Yields rose across the curve, with the pressure concentrated in the middle of it. A five-year note adding three basis points of yield while the thirty-year adds one is a market repricing the likely duration of restrictive policy. The dollar declined anyway, the one discordant note in an otherwise coherent day.
| Rates & volatility | Tue 9/8 | Fri 9/4 | Note |
|---|---|---|---|
| 2-year Treasury | 4.39% | 4.37% | |
| 5-year Treasury | 4.57% | 4.54% | Up three basis points |
| 10-year Treasury | 4.80% | 4.78% | Tops a four-session band |
| 30-year Treasury | 5.25% | 5.24% | |
| 2s10s spread | 41 bp | 41 bp | Held through the selling |
| Volatility index (VIX) | 15.72 | 15.30 |
| Commodity / dollar | Settle | % Chg | Note |
|---|---|---|---|
| WTI crude | $94.23 | +3.01% | Highest settle since early June |
| Brent crude | $99.29 | — | Within $0.71 of $100 |
| Gold (Dec futures) | $4,402.10 | -1.66% | |
| Natural gas | $2.903 | -2.42% | |
| Dollar index | 98.87 | -0.30% |
Every commodity figure above is an exchange settlement rather than the later screen quote. West Texas Intermediate is measured against Friday, since no American contract settled on Monday's holiday. Brent did settle in London on Monday, and the published Monday settlements differ by roughly forty cents, so its one-day change is left out.
Technicals
Three of the four major gauges closed under their twenty-day averages. A 7,673.52 finish put the S&P 500 beneath a 7,704.72 line it had held since Thursday; the Dow at 52,786.07 sits below both its twenty-day at 53,396.30 and its fifty-day at 52,962.99; the Russell 2000 at 2,960.20 is under 3,002.21 and 2,987.49. The Nasdaq Composite was the holdout at 26,421.41 against an average of 26,374.29. Beneath the broad index, a fifty-day at 7,598.10 sits about 1% away.
Rates were the quiet corner of this market for a week and stopped being quiet on Tuesday. The ten-year's 4.80% close takes out the top of the two-basis-point range it held for the four sessions of September so far, on a day whose only scheduled releases were second-tier.
Intel gapped open at $100.83, ran to $106.09, and held most of it into a $104.47 finish.
Breakouts and Breakdowns
Breakouts
Intel (INTC) cleared its fifty-day average at $100.13 and closed at $104.47, the highest finish since August 13. A June peak close of $140.94 sits another 34.9% higher.
Bloom Energy (BE) at $277.22 is its best close since July 6 and sits 22.1% above a fifty-day average of $226.98, a gap that leaves nothing underneath for some distance.
Breakdowns
United Airlines (UAL) closed at $108.24, back beneath the $108.37 two-hundred-day average it reclaimed on September 2. Jet fuel is the input behind it, and Delta (DAL) and Southwest (LUV) declined alongside.
Eli Lilly (LLY) lost 2.21% to $1,123.91 as investors marked down its own lipoprotein(a) programme, which leaves the shares below a fifty-day average of $1,189.82. The two-hundred-day at $1,063.80 is the next level with anything behind it.
Top Movers
Gainers
Intel (INTC) rose 9.05% to $104.47 on a supply-chain report that it will lift personal-computer processor prices about 10% in early October, and on an upgrade from Northland Securities analyst Gus Richard, who moved to Outperform with a $120 target. What the market liked is the choice a price increase implies: Intel is defending gross margin instead of chasing unit share. Tight server-processor supply is the condition that lets a price rise stick.
Qualcomm (QCOM) gained 3.17% to $174.09 after agreeing to co-develop custom silicon with Amazon Web Services across several generations of AI data-center hardware, including inference accelerators and 1.6-terabit optical interconnect. The arrangement runs to as much as $60 billion of purchases through 2036, with warrants issued to Amazon on 25 million shares struck at $161.26. The stock opened at $180.40 and closed $6.31 under that, a market taking the partnership seriously and the price much less so.
Bloom Energy (BE) added 9.63% to $277.22 in the first session after S&P Dow Jones Indices named it to the S&P 500, effective before the open on September 21. Index funds have to own it by then whatever they make of a fuel-cell company that has already tripled this year.
Tesla (TSLA) recovered 3.98% to $368.16 after Goldman Sachs analyst Mark Delaney told clients the Cybercab gives it a real cost advantage.
Losers
Amgen (AMGN) fell 10.08% to $393.17, its steepest single-session decline in at least five years on closing prices back to 2021. The trigger was somebody else's failure, and it had been sitting there since Friday evening: Novartis reported after the close on September 4 that pelacarsen, which lowers lipoprotein(a) as designed, did not reduce cardiovascular death, heart attack or stroke in its pivotal study. Tuesday was the first full session able to trade it. Amgen's olpasiran targets the same particle on the same logic, so a trial separating the biomarker from the outcome removed the premise rather than the execution. BMO Capital Markets cut the stock to Market Perform on Tuesday morning, and olpasiran's own outcomes study does not read out before late 2027. Novartis (NVS) took the larger hit, down 13.93% to $137.70 in New York, and its development partner Ionis Pharmaceuticals closed 2.38% lower after a far worse morning.
Casey's General Stores (CASY) lost 2.99% to $733.49 in the session and kept falling after the bell, quoted at $661.90 ninety minutes after the close. First-quarter earnings of $7.37 a share, up 27.7%, cleared the $6.68 analysts expected, so the selling is about what came with them: inside same-store sales grew 3.2% against 4.3% a year earlier, and management left the full-year outlook where it was.
Macro Calendar
Two second-tier readings landed while the market's attention was elsewhere.
| Release | Period | Reading | Note |
|---|---|---|---|
| NFIB Small Business Optimism | August | 98.7 | Above the 52-year average of 98.0 |
| Consumer credit, annualised | July | +4.2% | $18.06bn, above every forecast |
Revolving balances grew at a 2.5% annual rate while the total ran at 4.2%, so July's acceleration came from cars and tuition rather than card spending. With consumer prices up 3.4% over the year, card debt is shrinking in real terms even as the headline surprises upward. Small-business sentiment eased on soft sales.
Notable Earnings This Session
The morning was empty and the evening carried the week's first real slate.
Pre-Open
No company of consequence reported into the open.
Post-Close
GameStop (GME) turned in net sales of $790.2 million against $972.2 million a year earlier, above the $756.8 million analysts had modelled, with adjusted earnings of $0.27 a share versus $0.19 expected. Operating income reached $160.2 million against $66.4 million, and management lifted the full-year adjusted EBITDA target above $650 million from above $600 million. Collectibles were the engine, growing 57% to $356.3 million and supplying 45.1% of sales, which is a different company from the one the market stopped valuing. Shares eased 1.4% to $18.62 after hours. Casey's General Stores and Braze also reported into the evening.
Drivers
- Two inflation readings close out the week with the Federal Reserve due to meet on September 15-16: wholesale figures on Thursday, the consumer index on Friday. Tuesday made both harder to interpret. A three-percent move in crude cannot reach an August measure already collected, but it reaches every forecast written afterwards, and it lands on a committee whose chair has been citing a PCE gauge running at 3.7% over twelve months. Markets entered this week pricing roughly a 60% chance of an increase; Friday is what moves that number.
- Oracle (ORCL), at $162.52 after a 2.36% session, reports its fiscal first quarter on Thursday evening, having added 10.1% over three sessions on anticipation alone. Analysts model earnings of $1.74 a share on revenue of $19.13 billion. What actually sets the stock is remaining performance obligations, which stood at $638 billion three months ago.
- Canada's duties completed their first full session and the damage stayed narrow: industrials declined 0.48% while the index-level loss came from a drugmaker. The Dow's 52,786.07 close was its first finish below the fifty-day average since September 1.